Design, synthesis and evaluation of XZH-5 analogues as STAT3 inhibitors

被引:13
作者
Daka, Philias [1 ]
Liu, Aiguo [2 ]
Karunaratne, Chamini [1 ]
Csatary, Erika [1 ]
Williams, Cameron [1 ]
Xiao, Hui [3 ,4 ]
Lin, Jiayuh [3 ,4 ]
Xu, Zhenghu [5 ]
Page, Richard C. [1 ]
Wang, Hong [1 ]
机构
[1] Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pediat, Wuhan 430030, Hubei Province, Peoples R China
[3] Ohio State Univ, Dept Pediat, Nationwide Childrens Hosp, Ctr Childhood Canc & Blood Dis,Res Inst, Columbus, OH 43210 USA
[4] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA
[5] Shandong Univ, Sch Chem & Chem Engn, Jinan 250100, Peoples R China
关键词
STAT3; Inhibitor; SARs; SH2; Small organic molecule; Molecular docking; POTENT ANTITUMOR-ACTIVITY; SMALL-MOLECULE INHIBITOR; CANCER DRUG DISCOVERY; TRANSCRIPTIONAL CONTROL; ACTIVATION INHIBITOR; SIGNALING PATHWAY; INDUCE APOPTOSIS; MYELOMA CELLS; SH2; DOMAIN; IN-VIVO;
D O I
10.1016/j.bmc.2015.01.025
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inhibition of the signaling pathways of signal transducer and activator of transcription 3 (STAT 3) has shown to be a promising strategy to combat cancer. In this paper we report the design, synthesis and evaluation of a novel class of small molecule inhibitors, that is, XZH-5 and its analogues, as promising leads for further development of STAT3 inhibitors. Preliminary SARs was established for XZH-5 and its derivatives; and the binding modes were predicted by molecular docking. Lead compounds with IC50 as low as 6.5 mu M in breast cancer cell lines and 7.6 mu M in pancreatic cancer cell lines were identified. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1348 / 1355
页数:8
相关论文
共 48 条
[1]  
Barton BE, 2004, MOL CANCER THER, V3, P1183
[2]   Three-dimensional structure of the Stat3β homodimer bound to DNA [J].
Becker, S ;
Groner, B ;
Müller, CW .
NATURE, 1998, 394 (6689) :145-151
[3]  
Blaskovich MA, 2003, CANCER RES, V63, P1270
[4]   STATs in oncogenesis [J].
Bowman, T ;
Garcia, R ;
Turkson, J ;
Jove, R .
ONCOGENE, 2000, 19 (21) :2474-2488
[5]   The role of STATs in transcriptional control and their impact on cellular function [J].
Bromberg, J ;
Darnell, JE .
ONCOGENE, 2000, 19 (21) :2468-2473
[6]   Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells [J].
Catlett-Falcone, R ;
Landowski, TH ;
Oshiro, MM ;
Turkson, J ;
Levitzki, A ;
Savino, R ;
Ciliberto, G ;
Moscinski, L ;
Fernández-Luna, JL ;
Nuñez, G ;
Dalton, WS ;
Jove, R .
IMMUNITY, 1999, 10 (01) :105-115
[7]   Benchmarking and Analysis of Protein Docking Performance in Rosetta v3.2 [J].
Chaudhury, Sidhartha ;
Berrondo, Monica ;
Weitzner, Brian D. ;
Muthu, Pravin ;
Bergman, Hannah ;
Gray, Jeffrey J. .
PLOS ONE, 2011, 6 (08)
[8]   Design and synthesis of a new, conformationally constrained, macrocyclic small-molecule inhibitor of STAT3 via 'click chemistry' [J].
Chen, Jianyong ;
Nikolovska-Coleska, Zaneta ;
Yang, Chao-Yie ;
Gomez, Cindy ;
Gao, Wei ;
Krajewski, Krzysztof ;
Jiang, Sheng ;
Roller, Peter ;
Wang, Shaomeng .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (14) :3939-3942
[9]   Structure-Based Design of Conformationally Constrained, Cell-Permeable STAT3 Inhibitors [J].
Chen, Jianyong ;
Bai, Longchuan ;
Bernard, Denzil ;
Nikolovska-Coleska, Zaneta ;
Gomez, Cindy ;
Zhang, Jian ;
Yi, Han ;
Wang, Shaomeng .
ACS MEDICINAL CHEMISTRY LETTERS, 2010, 1 (02) :85-89
[10]   Computation of octanol-water partition coefficients by guiding an additive model with knowledge [J].
Cheng, Tiejun ;
Zhao, Yuan ;
Li, Xun ;
Lin, Fu ;
Xu, Yong ;
Zhang, Xinglong ;
Li, Yan ;
Wang, Renxiao ;
Lai, Luhua .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2007, 47 (06) :2140-2148